Table 1.

Case examples of indicated IMTF patients and their postoperative outcomes.

Patient number	Age	Gender	BMI (kg/m2)	Indication	OR time (minutes)	Assistive devices	Follow-up (months)	Complication(s)
1	71	Female	25.1	Prior nonarticulating stage 1 hip spacer for arecurrent infection, instability, and periprosthetic femur fracture	274	FWW	6
2	56	Female	53.1	Complex intra-articular distal femur fracture with an ipsilateral articulating spacer for prosthetic joint infection from prior THA	222	FWW	6	Superficial wound dehiscence
3	78	Female	21.9	Subsidence and loosening about a prior proximal femoral replacement with ipsilateral knee osteoarthritis	211	Cane	9
4	70	Female	41.7	Prosthetic joint infection about a distal femur replacement and ipsilateral THA with subsequent stage 1 spacer	310	Cane	40	PJI s/p 2 stage and repeat IMTF
5	69	Male	28.2	Aseptic loosening of prior long distal femoral replacement for distal femur fracture with ipsilateral hip osteoarthritis	316	None	58
6	80	Female	27.6	Subsidence and loosening about a prior proximal femoral replacement with ipsilateral knee osteoarthritis	367	FWW	74

BMI, body mass index; FWW, front wheeled walker; OR, operating room.